Denture cream: An unusual source of excess zinc, leading to hypocupremia and neurologic disease

Neurology

Volumn 71, Issue 9, 2008, Pages 639-643

  Nations, S P ^a   Boyer, P J ^c   Love, L A ^a   Burritt, M F ^d   Butz, J A ^d   Wolfe, G I ^a   Hynan, L S ^b   Reisch, J ^b   Trivedi, J R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; PROTEIN; ZINC; TISSUE ADHESIVE;

ADULT; ARTICLE; BLOOD DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERULOPLASMIN BLOOD LEVEL; CLINICAL STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; CREAM; DENTURE; ELECTROMYOGRAPHY; FEMALE; HUMAN; HYPERZINCEMIA; HYPOCUPREMIA; INGESTION; LEUKOCYTE COUNT; LIMB WEAKNESS; MALE; MASS SPECTROMETRY; NERVE CONDUCTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPRIOCEPTION; PROTEIN BLOOD LEVEL; VIBRATION SENSE; ZINC BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; SPINAL CORD DISEASE;

ADULT; CENTRAL NERVOUS SYSTEM; COPPER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; TISSUE ADHESIVES; ZINC;

EID: 52449131277     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000312375.79881.94     Document Type: Article

References (33)

1. Kumar N. Copper deficiency myelopathy (human sway-back). Mayo Clin Proc 2006;81:1371-1384.
2. Kumar N, Gross JB, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 2004;63:33-39.
3. Greenberg SA, Briemberg HR. A neurological and hematological syndrome with zinc excess and copper deficiency. J Neurol 2004;251:111-114.
4. Weihl CC, Lopate G. Motor neuron disease associated with copper deficiency. Muscle Nerve 2006;34:789-793.
5. Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood 2002;100: 1493-1495.
6. Porter KG, McMaster D, Elmes ME, Love AH. Anaemia and low serum-copper during zinc therapy. Lancet 1977;2: 774.
7. Willis MS, Monaghan SA, Miller ML, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol 2005;123:125-131.
8. Goulle JP, Mahieu L, Castermant J, et al. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair: reference values. Forensic Sci Int 2005;153:39-44.
9. Cai L, Li XK, Song Y, Cherian MG. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem 2005;12:2753-2763.
10. Kumar N, McEvoy KM, Ahlskog JE. Myelopathy due to copper deficiency following gastrointestinal surgery. Arch Neurol 2003;60:1782-1785.
11. Rowin J, Lewis SL. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry 2005;76:750-751.
12. Kumar N, Ahlskog EJ, Klein CJ, Port JD. Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiol 2006;48:78-83.
13. Tan N, Urich H. Menkes' disease and swayback. A comparative study of two copper deficiency syndromes. J Neurol Sci 1983;62:95-113.
14. Hamano H, Ohta T, Takekawa Y, Kouda K, Shinohara Y. Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report. Rinsho Shinkeigaku 1997; 37:917-922.
15. Goyens P, Brasseur D, Cadranel S. Copper deficiency in infants with active celiac disease. J Pediatr Gastroenterol Nutr 1985;4:677-680.
16. Kaler SG. Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency. Am J Clin Nutr 1998; 67:1029S-1034S.
17. Fuhrman MP, Herrmann V, Masidonski P, Eby C. Pancy-topenia after removal of copper from total parenteral nutrition. JPEN J Parenter Enteral Nutr 2000;24:361-366.
18. Brewer GJ, Dick RD, Grover DK, et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin Cancer Res 2000;6:1-10.
19. Broun ER, Greist A, Tricot G, Hoffman R. Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA 1990;264:1441-1443.
20. Fiske DN, McCoy HE III, Kitchens CS. Zinc-induced sideroblastic anemia: report of a case, review of the literature, and description of the hematologic syndrome. Am J Hematol 1994;46:147-150.
21. Cragg RA, Phillips SR, Piper JM, et al. Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation. Gut 2005;54:469-478.
22. Chimienti F, Aouffen M, Favier A, Seve M. Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets 2003;4:323-338.
23. Brewer GJ, Hill GM, Prasad AS, et al. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-319.
24. Hedera P, Fink JK, Bockenstedt PL, Brewer GJ. Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin; further support for existence of a new zinc overload syndrome. Arch Neurol 2003;60:1303-1306.
25. Shay K. Treatment of an edentulous patient with a dry mouth. J Contemp Dent Pract 2000;1:98.
26. Coates AJ. Usage of denture adhesives. J Dent 2000;28: 137-140.
27. Zinc. Facts about dietary supplements. Washington, DC: Clinical Nutrition Service, Office of Dietary Supplements, National Institutes of Health. Available at: http://ods.od-.nih.gov/factsheets/cc/zinc.pdf. Accessed March 6, 2007.
28. Smith JC, Zeller JA, Brown ED, Ong SC. Elevated plasma zinc: a heritable anomaly. Science 1976;193:496-498.
29. Failla ML, van de Veerdonk M, Morgan WT, Smith JC Jr. Characterization of zinc-binding proteins of plasma in familial hyperzincemia. J Lab Clin Med 1982;100:943-952.
30. Selimoglu MA, Ertekin V, Yildirim ZK, Altinkaynak S. Familial hyperzincaemia: a rare entity. Int J Clin Pract 2006;60:108-109.
31. Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS. CNS demyelination associated with copper deficiency and hyperzincemia. Neurology 2002;59:1453-1456.
32. Schleper B, Stuerenburg HJ. Copper deficiency-associated myelopathy in a 46-year-old woman. J Neurol 2001;248: 705-706.
33. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107-116.